{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:51Z","timestamp":1707524631223},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,24]]},"DOI":"10.7759\/cureus.29527","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T14:07:06Z","timestamp":1664028426000},"source":"Crossref","is-referenced-by-count":0,"title":["Expression of c-Myc, Bcl2, Bcl6, and Cyclin D1 in High-Grade B-Cell Lymphoma"],"prefix":"10.7759","author":[{"given":"Seemal","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zonaira","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fizza","family":"Jahangir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zubaria","family":"Rafique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhtar S","family":"Chughtai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aribah","family":"Atiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12254-017-0367-8","article-title":"Aggressive lymphoma 2016: revision of the WHO classification","volume":"10","author":"Beham-Schmid C","year":"2017","unstructured":"Beham-Schmid C. Aggressive lymphoma 2016: revision of the WHO classification. Memo. 2017, 10:248-54. 10.1007\/s12254-017-0367-8","journal-title":"Memo"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow SH","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al.. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016, 127:2375-90. 10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071620","article-title":"High-grade B-cell lymphoma (HGBL) with MYC and BCL2 and\/or BCL6 rearrangements is predominantly BCL6-rearranged and BCL6-expressing in Taiwan","volume":"13","author":"Tsai CC","year":"2021","unstructured":"Tsai CC, Su YC, Bamodu OA, et al.. High-grade B-cell lymphoma (HGBL) with MYC and BCL2 and\/or BCL6 rearrangements is predominantly BCL6-rearranged and BCL6-expressing in Taiwan. Cancers (Basel). 2021, 13:1620. 10.3390\/cancers13071620","journal-title":"Cancers (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-120147","article-title":"Quadruple hit lymphoma: a rare entity with dismal prognosis","volume":"132","author":"Proulx J","year":"2018","unstructured":"Proulx J, Denley R, Pedemonte BM, et al.. Quadruple hit lymphoma: a rare entity with dismal prognosis. Blood. 2018, 132:5305. 10.1182\/blood-2018-99-120147","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26151","article-title":"2021 update on diffuse large B cell lymphoma: a review of current data and potential applications on risk stratification and management","volume":"96","author":"Susanibar-Adaniya S","year":"2021","unstructured":"Susanibar-Adaniya S, Barta SK. 2021 update on diffuse large B cell lymphoma: a review of current data and potential applications on risk stratification and management. Am J Hematol. 2021, 96:617-29. 10.1002\/ajh.26151","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2020.21.4.1103","article-title":"The frequency of double expresser in selected cases of high grade diffuse large B-cell lymphomas","volume":"21","author":"Naseem M","year":"2020","unstructured":"Naseem M, Asif M, Khadim MT, Ud-Din H, Jamal S, Shoaib I. The frequency of double expresser in selected cases of high grade diffuse large B-cell lymphomas. Asian Pac J Cancer Prev. 2020, 21:1103-7. 10.31557\/APJCP.2020.21.4.1103","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2021.06.121","article-title":"High-grade B-cell lymphoma with concurrent expression of CD5 and cyclin D1 and MYC rearrangement","volume":"54","author":"Fratoni S","year":"2022","unstructured":"Fratoni S, Ardu N, Zhao XF, Morino L, Niscola P, Bianchi A. High-grade B-cell lymphoma with concurrent expression of CD5 and cyclin D1 and MYC rearrangement. Pathology. 2022, 54:490-3. 10.1016\/j.pathol.2021.06.121","journal-title":"Pathology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26433","article-title":"Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma","volume":"118","author":"Lin P","year":"2012","unstructured":"Lin P, Dickason TJ, Fayad LE, et al.. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Cancer. 2012, 118:1566-73. 10.1002\/cncr.26433","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S243753","article-title":"High-grade B-cell lymphomas, not otherwise specified: a study of 41 cases","volume":"12","author":"Li J","year":"2020","unstructured":"Li J, Liu X, Yao Z, Zhang M. High-grade B-cell lymphomas, not otherwise specified: a study of 41 cases. Cancer Manag Res. 2020, 12:1903-12. 10.2147\/CMAR.S243753","journal-title":"Cancer Manag Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2019.04.002","article-title":"Double or triple-expressor lymphomas: prognostic impact of immunohistochemistry in patients with diffuse large B-cell lymphoma","volume":"42","author":"Pe\u00f1a C","year":"2020","unstructured":"Pe\u00f1a C, Villegas P, Cabrera ME. Double or triple-expressor lymphomas: prognostic impact of immunohistochemistry in patients with diffuse large B-cell lymphoma. Hematol Transfus Cell Ther. 2020, 42:192-3. 10.1016\/j.htct.2019.04.002","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.540361","article-title":"Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus","volume":"52","author":"Vela-Ch\u00e1vez T","year":"2011","unstructured":"Vela-Ch\u00e1vez T, Adam P, Kremer M, et al.. Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus. Leuk Lymphoma. 2011, 52:458-66. 10.3109\/10428194.2010.540361","journal-title":"Leuk Lymphoma"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122648","article-title":"Cyclin D1 in cancer: A molecular connection for cell cycle control, adhesion and invasion in tumor and stroma","volume":"9","author":"Montalto FI","year":"2020","unstructured":"Montalto FI, De Amicis F. Cyclin D1 in cancer: A molecular connection for cell cycle control, adhesion and invasion in tumor and stroma. Cells. 2020, 9:2648. 10.3390\/cells9122648","journal-title":"Cells"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-461848","article-title":"CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"121","author":"Hu S","year":"2013","unstructured":"Hu S, Xu-Monette ZY, Balasubramanyam A, et al.. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Blood. 2013, 121:2715-24. 10.1182\/blood-2012-10-461848","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.03.021","article-title":"CD5(-) diffuse large B-cell lymphoma with peculiar cyclin D1+ phenotype. Pathologic and molecular characterization of a single case","volume":"43","author":"Izquierdo F","year":"2012","unstructured":"Izquierdo F, Su\u00e1rez D. CD5(-) diffuse large B-cell lymphoma with peculiar cyclin D1+ phenotype. Pathologic and molecular characterization of a single case. Hum Pathol. 2012, 43:1344-5. 10.1016\/j.humpath.2012.03.021","journal-title":"Hum Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.173","article-title":"Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes","volume":"23","author":"Metcalf RA","year":"2010","unstructured":"Metcalf RA, Zhao S, Anderson MW, et al.. Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes. Mod Pathol. 2010, 23:420-33. 10.1038\/modpathol.2009.173","journal-title":"Mod Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4658","article-title":"Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas","volume":"35","author":"Zlamalikova L","year":"2016","unstructured":"Zlamalikova L, Moulis M, Salek D, Jarkovsky J, Smarda J, Smardova J. Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas. Oncol Rep. 2016, 35:2673-80. 10.3892\/or.2016.4658","journal-title":"Oncol Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1309\/42CQ0HU7XEY9QMQX","article-title":"A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus","volume":"129","author":"Ehinger M","year":"2008","unstructured":"Ehinger M, Linderoth J, Christensson B, Sander B, Cavallin-St\u00e5hl E. A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus. Am J Clin Pathol. 2008, 129:630-8. 10.1309\/42CQ0HU7XEY9QMQX","journal-title":"Am J Clin Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/111936-expression-of-c-myc-bcl2-bcl6-and-cyclin-d1-in-high-grade-b-cell-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:37Z","timestamp":1707508117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/111936-expression-of-c-myc-bcl2-bcl6-and-cyclin-d1-in-high-grade-b-cell-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,24]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.29527","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,24]]}}}